Page 239 - MSU Digital Book

เอกสำารอ้างอิง

1. de Boer S, Klewitz F, Bauer-Hohmann M, Schiffer L, Tegtbur U, Pape L, et al.
Knowledge about immunosuppressant medication and its correlates in a German

kidney transplant population - results of a KTx360° substudy. patient prefer
adherence. 2020;14:1699-708.
2. Dobbels F, Moons P, Abraham I, Larsen CP, Dupont L, De Geest S. Measuring

symptom experience of side-effects of immunosuppressive drugs: the Modified
Transplant Symptom Occurrence and Distress Scale. Transpl Int. 2008;21:764-73.

3. Meaney CJ, Arabi Z, Venuto RC, Consiglio JD, Wilding GE, Tornatore KM. Validity and
reliability of a novel immunosuppressive adverse effects scoring system in renal
transplant recipients. BMC Nephrol. 2014;15:88.

4. Ordin YS, Karayurt O, Cilengiroğlu OV. Validation and adaptation of the Modified
Transplant Symptom Occurrence and Symptom Distress Scale-59 Items revised

into Turkish. Prog Transplant. 2013;23:392-400.
ั
่
ั
่
�
ั
์
5. อ้วรู้รู้ณี โศึภูต้สกี่ล, วรู้รู้ณีภูา ปรู้ะไพพานช้, วนทำนา มณีศึรู้่วงศึกี่้ล. ปจจยทำม่ความสมพนธกี่บื้
ิ
ั
ิ
ั
ั
์
่
่
ำ
�
�
�
้
ิ
กี่ารู้รู้บื้ปรู้ะทำานยาอยางต้อเนองสมาเสมอในผู้ปวยหลงปลกี่ถ่ายไต้. รู้ามาธบื้ดพยาบื้าลสารู้.
่
้
้
่
ั
ั
่
2561;24:328-44.
6. Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT. Impact of clinical pharmacy
services on renal transplant patients’ compliance with immunosuppressive
medications. Clin Transplant. 2001;15:330-6.
7. Chisholm-Burns MA, Spivey CA, Graff Zivin J, Lee JK, Sredzinski E, Tolley EA.
Improving outcomes of renal transplant recipients with behavioral adherence
contracts: a randomized controlled trial. Am J Transplant. 2013;13:2364-73.
8. Joost R, Dörje F, Schwitulla J, Eckardt KU, Hugo C. Intensified pharmaceutical
care is improving immunosuppressive medication adherence in kidney transplant
recipients during the first post-transplant year: a quasi-experimental study. Nephrol
Dial Transplant. 2014;29:1597-607.
9. Tschida S, Aslam S, Khan TT, Sahli B, Shrank WH, Lal LS. Managing specialty
medication services through a specialty pharmacy program: the case of oral renal
transplant immunosuppressant medications. J Manag Care Pharm. 2013;19:26-41.
10. Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to
measure treatment adherence. Med Pharm Rep. 2019;92:117-22.
214